Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its wholly owned subsidiary, MindWave Innovations Inc. USA, has entered into three separate agreements to build and operate dedicated blockchain networks on its MindChain infrastructure. The agreements, signed between September 24 and October 4, 2026, cover clients in climate finance, sports media, and insurance, signaling a strategic expansion into diverse industries that could benefit from blockchain's transparency and traceability features.
The first agreement is with Singapore-based AQUAE Holdings for its AQUAEChain environmental credit platform. The second is with New York-based Flash Sports & Media Holdings for its FlashChain digital ticketing and media authentication network. The third is with Delaware-based BlockAssure for its AssureChain insurance and reinsurance network. Under these agreements, MindWave will receive contracted fees or equity, along with allocations equal to 20% of the applicable credits or tokens, providing opportunities for recurring revenue as the networks become operational.
This move matters because it demonstrates MindWave's ability to commercialize its blockchain technology across multiple sectors, potentially opening new revenue streams and enhancing shareholder value. The climate finance sector is increasingly turning to blockchain for carbon credit tracking, while sports media seeks to combat ticketing fraud and authenticate digital content. The insurance industry, meanwhile, is exploring blockchain for reinsurance efficiency and claims processing. By securing these deals, MindWave positions itself as a key infrastructure provider in these emerging markets.
However, the announcement also includes a cautionary note. Apimeds reiterated that its audited consolidated financial statements for 2025 included an explanatory paragraph from its independent auditor expressing substantial doubt about its ability to continue as a going concern. This disclosure was made pursuant to NYSE American requirements and does not amend the company's previous filings. The going concern doubt casts a shadow over the company's future, despite the promising blockchain agreements.
Investors should weigh the potential of these new contracts against the company's financial health. The recurring revenue from the blockchain networks could improve Apimeds' financial position if the networks gain traction. Yet, the substantial doubt raised by auditors suggests that the company may face liquidity or solvency challenges in the near term. The success of these agreements will depend on MindWave's ability to execute and scale the networks, as well as the adoption by the clients' respective industries.
For more details, the full press release is available at https://ibn.fm/UPsNX. The latest news and updates relating to APUS can be found in the company's newsroom at https://ibn.fm/APUS. MissionIR, a specialized communications platform, distributes this content as part of its services. It is one of 75+ brands within the Dynamic Brand Portfolio at IBN, which offers access to wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, and social media distribution. For more information, visit MissionIR.
